NCT06158360 An Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T)
| NCT ID | NCT06158360 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ilsan Cha hospital |
| Condition | Thyroid Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-12-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-12-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study aimed to evaluate the safety and efficacy of postoperative management in patients with thyroid cancer who received subtotal or total thyroidectomy.
Eligibility Criteria
Inclusion Criteria: * 19 years of age or older * Those who have been confirmed to have a malignant tumor of the thyroid gland by biopsy or imaging * Subjects who have undergone partial thyroidectomy or total resection within 1 month * Those who have agreed to the implementation of Chinese medicine treatment * The Eastern Cooperative Oncology Group(ECOG) performance status 0-3 * Those who understand the content of the study and agree to participate in the study Exclusion Criteria: * ○ When it is judged that other diseases other than cancer (dementia, cerebrovascular disease, severe organ failure, etc.) may have a significant effect on the decline of physical function * When it is judged that the life expectancy is less than 3 months and sufficient follow-up cannot be carried out * When emergency or major surgery or surgical intervention is required that takes precedence over postoperative treatment * Pregnant and lactating women * Other researchers who are judged to be unsuitable for research
Contact & Investigator
Jee Youg Lee
PRINCIPAL INVESTIGATOR
Ilsan Cha hospital
Frequently Asked Questions
Who can join the NCT06158360 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Thyroid Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06158360 currently recruiting?
Yes, NCT06158360 is actively recruiting participants. Contact the research team at happiade@chamc.co.kr for enrollment information.
Where is the NCT06158360 trial being conducted?
This trial is being conducted at Gyeonggi-do, South Korea, Gyeonggi-do, South Korea, Seoul, South Korea.
Who is sponsoring the NCT06158360 clinical trial?
NCT06158360 is sponsored by Ilsan Cha hospital. The principal investigator is Jee Youg Lee at Ilsan Cha hospital. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.